Abstract
Amongst patients with end-stage lung disease (ESLD), symptoms and diagnostic evidence of gastroesophageal reflux disease (GERD) are extremely common. In fact, roughly two-thirds of all patients with ESLD have documentable gastroesophageal reflux [1]. The presence of significant reflux is not limited to one pulmonary disease, but is seen in patients with ESLD secondary to COPD, cystic fibrosis and idiopathic pulmonary fibrosis (IPF) [2] (Gasper et al. 2007). While the pathophysiology of COPD and cystic fibrosis are well understood, it remains unknown what leads to the eventual development of IPF. Interestingly, evidence has continued to mount over the last 20 years that reflux is not just prevalent in patients with IPF, but may in fact be contributing to its development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
D’Ovidio F, Singer L, Hadjiliadis D, et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg. 2005;80:1254–61.
Sweet M, Herbella F, Leard L, et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244:491–7.
Gasper W, Sweet M, Golden J, et al. Lung transplantation in patients with connective tissue disorders and esophageal dysmotility. Dis Esophagus. 2008;21:650–5.
Reid K, McKenzie F, Menkis A, et al. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet. 1990;336:206–8.
Rinaldi M, Martinelli L, Volpato G, et al. Gastroesophageal reflux as a cause of obliterative bronchiolitis: a case report. Transplant Proc. 1995;27:2006–7.
Hartwig M, Anderson D, Onaitis M, et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg. 2011;92:462–9.
Birring S. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med. 2010;183:709–15.
Fathi H, Wright C, Thompson R, et al. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology. 2011;16:1150–6.
Mastronarde J, Anthonisen N, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360:1487–99.
Irwin R, Baumann M, Bolser D, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:1S–23S.
Patti M, Tedesco P, Golden J, et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J Gastrointest Surg. 2005;9:1053–8.
Raghu G. The role of gastroesophageal reflux in idiopathic pulmonary fibrosis. Am J Med. 2003;115:60S–4S.
Glauser FL, Millen JE, Falls R, et al. Increased alveolar epithelial permeability with acid aspiration: the effects of high-dose steroids. Am Rev Respir Dis. 1970;120:1119–23.
Salley S, Santo G, Barnhart M, et al. Immediate histopathology of hydrocholoric acid aspiration. Scan Electron Microsc. 1970;3:911–20.
Schwartz D, Wynne J, Gibbs C, et al. The pulmonary consequences of aspiration of gastric contents at pH values greater than 2.5. Am Rev Respir Dis. 1980;121:119–26.
el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113:755–60.
Mays E, Dubois J, Hamilton G, et al. Pulmonary fibrosis associated with tracheobronchial aspiration: a study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest. 1976;69:512–5.
Sweet M, Patti M, Leard L, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg. 2007;133:1078–84.
Beck-Schimmer B, Bonvini J. Bronchoaspiration: incidence, consequences and management. Eur J Anaesthesiol. 2011;28:78–84.
Hu X, Lee J, Pianosi P, et al. Aspiration-related pulmonary syndromes. Chest. 2015;147:815–23.
Marik P. Pulmonary aspiration syndromes. Curr Opin Pulm Med. 2011;17:148–54.
Kennedy T, Johnson K, Kunkel R, et al. Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth Analg. 1989;69:87–92.
Madjdpour L, Kneller S, Booy C, et al. Acid-induced lung injury: role of nuclear factor-κB. Anesthesiology. 2003;99:1323–32.
Appel J, Lee S, Hartwig M, et al. Characterization of the innate response to chronic aspiration in a novel rodent model. Respir Res. 2007;8:87.
Tobin R, Pope C, Pellegrini C, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;158:1804–8.
Raghu G, Freudenberger T, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136–42.
Lee J, Collard H, Raghu G, et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis. Am J Med. 2010;123:304–11.
Lee J, Ryu J, Elicker B, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:1390–4.
Linden P, Gilbert R, Yeap B, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006;131:438–46.
Young L, Hadjiliadis D, Davis D, et al. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124:1689–93.
Li B, Hartwig M, Appel J, et al. Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant. 2008;8:1614–21.
Palmer S, Miralles A, Howell D, et al. Gastresophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest. 2000;118:1214–7.
Blondeau K, Mertens V, Vanaudenaerde B, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J. 2008;31:707–13.
Fisichella P, Davis C, Gagermeier J, et al. Laparoscopic antireflux surgery for gastroesophageal reflux disease after lung transplantation. J Surg Res. 2011;170:e279–86.
Fisichella P, Davis C, Lundberg P, et al. The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation. Surgery. 2011;150:598–606.
Stovold R, Forrest I, Corris P, et al. Pepsin, a biomarker of gastric aspiration in lung allografts. Am J Respir Crit Care Med. 2007;175:1298–303.
Shah N, Force S, Mitchell P, et al. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts. Transplant Proc. 2010;42:2702–6.
Ward C, Forrest I, Brownlee I, et al. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax. 2005;60:872–4.
D’Ovidio F, Mura M, Ridsdale R, et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules of SP-A and SP-D. Am J Transplant. 2006;6:1930–8.
Berkowitz N, Shulman L, McGregor C, et al. Gastroparesis after lung transplantation: potential role in postoperative respiratory complications. Chest. 1995;108:1602–7.
Bhashyam A, Mogayzel P, Cleary J, et al. Vagal control of mucociliary clearance in murine lungs: a study in a chronic preparation. Auton Neurosci. 2010;154:74–8.
Pazetti R, Pêgo-Fernandes P, Jatene F. Adverse effects of immunosuppressant drugs upon airway epithelial and mucociliary clearance: implications for lung transplant recipients. Drugs. 2013;73:1157–69.
Fisichella P, Davis C, Lowery E, et al. Pulmonary immune changes early after laparoscopic antireflux surgery in lung transplant patients with gastroesophageal reflux disease. J Surg Res. 2012;177:e65–73.
Cantu E, Appel J, Hartwig M, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78:1142–51.
Robertson A, Krishman A, Ward C, et al. Anti-reflux in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J. 2012;39:691–7.
Hoppo T, Jarido V, Pennathur A, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg. 2011;146:1041–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Klapper, J.A., Gulack, B., Hartwig, M.G. (2018). Reflux and Aspiration: Their Presumed Role in Chronic Cough and the Development of End-Stage Lung Disease. In: Morice, A., Dettmar, P. (eds) Reflux Aspiration and Lung Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-90525-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-90525-9_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90523-5
Online ISBN: 978-3-319-90525-9
eBook Packages: MedicineMedicine (R0)